Prosecution Insights
Last updated: April 19, 2026
Application No. 18/050,415

SILK-BASED ELECTROSPUN MATERIALS FOR IMPLANT SYSTEMS AND DEVICES

Non-Final OA §103
Filed
Oct 27, 2022
Examiner
MATHEW, SEEMA
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Edwards Lifesciences Corporation
OA Round
2 (Non-Final)
71%
Grant Probability
Favorable
2-3
OA Rounds
3y 4m
To Grant
98%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allow Rate
491 granted / 689 resolved
+1.3% vs TC avg
Strong +26% interview lift
Without
With
+26.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
29 currently pending
Career history
718
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
46.6%
+6.6% vs TC avg
§102
29.3%
-10.7% vs TC avg
§112
14.6%
-25.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 689 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is responsive to the amendment filed on 10/30/2025. As directed by the amendment: claims 10-20 have been canceled, and new claims 21-31 have been added. Thus, claims 1-9, 21-31 are presently pending in the application. Response to Arguments Applicant's arguments filed page 9 of the remarks filed on 10/30/2025 have been fully considered are persuasive. Applicant argues the prior art Pelled discloses polymeric layers 84 and 86 formed by electrospining process, but does not disclose the electrospun polymers may comprise silk. Although the examiner agrees with the argument, Pelled discloses in an alternative embodment, see in Figures 21-24, sealing member 300 may be made from any various fabrics including natural fibers such as silk. Allowable Subject Matter Claims 4 and 8 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The prior art fails to teach nor render obvious wherein the plurality of undulations are present in the collapsed configuration, and wherein the plurality of undulations are configured to straighten when the implantable prosthetic valve is in the expanded configuration and wherein at least a portion of the inner skirt further comprises a first perforated material having a first surface facing the annular frame and an opposite second surface and wherein the first material is disposed on the first surface and/or the second surface of the first perforated material; and/or wherein at least a portion of the outer skirt further comprises a second perforated material having a first surface facing the annular frame and an opposite second surface and wherein the second material is disposed on the first surface and/or the second surface of the second perforated material; and/or wherein at least a portion of the leaflet structure comprises a third perforated material having a first surface facing the annular frame and an opposite second surface and wherein the third material is disposed on the first surface and/or the second surface of the third perforated material; and/or wherein the first, second, and/or third perforated material comprises a porous fabric or membrane, wherein the porous fabric or membrane comprises one or more biocompatible polymers that are resorbable, non-resorbable or a combination thereof. Claim 31 is allowed. The following is a statement of reasons for the indication of allowable subject matter: the prior art fails to teach wherein each fiber of the plurality of fibers has a first extending direction and a plurality of undulations; and wherein the implantable prosthetic valve is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration; and wherein the plurality of undulations are present in the collapsed configuration, and wherein the plurality of undulations are configured to straighten when the implantable prosthetic valve is in the expanded configuration. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-2, 5-7 and 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Pelled et al. U.S. Publication 2016/0317305 A1. Regarding Claim 1, Pelled et al. discloses an implantable prosthetic valve comprising: an annular frame 310 having an inner surface and an outer surface (Figure 23-24), wherein the frame has an inflow end and an outflow end, and a central longitudinal axis extending from the inflow end to the outflow end; a leaflet structure 14 positioned within the frame (as seen in Figures 1-3 and paragraphs [0021-0022]); an inner skirt 302 positioned along the inner surface of the frame 12; at least one outer skirt 306 positioned around the outer surface of the frame 12; wherein at least a portion of one of the leaflet structure, the inner skirt, or the at least one outer skirt comprises a material comprising a plurality of fibers (paragraph [0065], [0069]) and wherein the implantable prosthetic valve is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration (abstract and paragraphs [0023], [0029] and [0057]). However, in the embodiment used in the rejection above, Figures 21-24 does not expressly disclose wherein at least one fiber of the plurality of fibers comprises electrospun silk. However, in an alternative embodiment, Figures 18-19f, Pelled et al. teaches a sealing member 16 formed from also laminated/encapsulated between one or more layers or filaments of ePTFE and fabric (paragraphs [0035-0036]), wherein the laminate sealing member is formed from a plurality of polymer fibers that is formed using an electrospining process ([0041], [0047] and [0069]) for the purpose of encapsulating the frame with the polymer sealing material using an electrical charge to drawn very fine fibers from a liquid to encapsulating the fibers to the frame (paragraph [0047]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include at least one fiber formed from electrospining as taught in Figures 18-20 for the purpose of encapsulating the frame with the polymer sealing material using an electrical charge to drawn very fine fibers from a liquid to encapsulating the fibers to the frame. Regarding Claim 2, Pelled et al. discloses wherein at least a portion of the inner skirt comprises the material comprising the plurality of fibers (paragraphs [0041], [0047], [0069]), and wherein the material present in the at least a portion of the inner skirt is a first material (formed of two different tubes of polymer, see paragraph [0041]), wherein the first material has a first surface facing the annular frame and an opposite second surface (as seen in Figure 18); and/or wherein at least a portion of the outer skirt comprises the material comprising the plurality of fibers, and wherein the material present in the at least a portion of the outer skirt is a second material (formed of two different tubes of polymer, see paragraph [0041]), wherein the second material has a first surface facing the annular frame and an opposite second surface (as seen in Figure 18); and/or wherein at least a portion of the leaflet structure comprises the material comprising the plurality of fibers, and wherein the material present in the at least a portion of the leaflet structure is a third material (paragraph [0022], pericardial tissue), wherein the third material has a first surface facing the annular frame and an opposite second surface (as seen in Figure 2). Regarding Claim 5, Pelled et al. discloses wherein at least a portion of the inner skirt is attached to the annular frame by direct electrospinning of the plurality of fibers on at least a portion of the inner surface of the annular frame (paragraphs [0041-0042]); and/or wherein at least a portion of the outer skirt is attached to at least a portion of the annular frame by direct electrospinning of the plurality of fibers on at least a portion of the outer surface of the annular frame (paragraphs [0041-0042]). Regarding Claim 6, Pelled et al. discloses wherein the plurality of fibers further comprise thermoplastic polyurethane (TPU), polyurethane (PU), implantable elastane polymer, polyester (PET), ultra-high molecular weight polyethylene (UHMWPE), polytetrafluorethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), Polyvinylidene fluoride (PVDF), Polyamides (Nylons), polypropylene, polyetheretherketone (PEEK), polyglycolic acid (PGA), poly(ester urethane)urea, polylactic acid (PLA), polycaprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA) or any combination thereof (paragraph [0041]). Regarding Claim 7, Pelled et al. discloses wherein the plurality of fibers comprises a biocompatible fiber (paragraph [0041]). Regarding Claim 9, Pelled et al. discloses sealing member 300 having an inner skirt 302 and outer skirt 306 can be laminated with or encapsulated between one or more films of ePTFE (paragraph [0071]). However, in the embodiment used in the rejection above, Figures 21-24 does not expressly disclose wherein at least a portion of the first surface of the first material comprises a first auxiliary layer, and/or wherein the first, second, and/or third auxiliary layer comprises one or more thermoplastic polyurethane (TPU), polyurethane (PU); implantable elastane polymer, or polyethylene, polypropylene, polymethylmethacrylate (PMMA), polystyrene (PS), polytetrafluoroethylene (PTFE), polyamide, polyethylene terephthalate (PET), polyethersulfone, poly-lactic-co-glycolic acid (PLGA). In an alternative embodiment as seen in Figures 18-20, Pelled et al. teaches wherein at least a portion of the first surface of the first material comprises a first auxiliary layer 18 (a reinforcing layer, paragraphs [0035-0036] and as seen in Figures 17-19C), and/or wherein the first, second, and/or third auxiliary layer comprises one or more thermoplastic polyurethane (TPU), polyurethane (PU); implantable elastane polymer, or polyethylene, polypropylene, polymethylmethacrylate (PMMA), polystyrene (PS), polytetrafluoroethylene (PTFE), polyamide, polyethylene terephthalate (PET), polyethersulfone, poly-lactic-co-glycolic acid (PLGA) (see paragraph [0038]) for the purpose of encapsulating portion of the frame with a plurality of layers that strengthen the sealing member 16 and resist tearing and prevent paravalvular leakage (paragraph [0039]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include at least a portion of the first surface of the first material comprises a first auxiliary layer formed from one or more thermoplastic polyurethane (TPU), polyurethane (PU); implantable elastane polymer, or polyethylene, polypropylene, polymethylmethacrylate (PMMA), polystyrene (PS), polytetrafluoroethylene (PTFE), polyamide, polyethylene terephthalate (PET), polyethersulfone, poly-lactic-co-glycolic acid (PLGA) as taught in Figures 18-20 for the purpose of encapsulating portion of the frame with a plurality of layers that strengthen the sealing member and resist tearing and prevent paravalvular leakage. Claim(s) 3 is/are rejected under 35 U.S.C. 103 as being unpatentable over Pelled et al. U.S. Publication 2016/0317305 A1 in view of Levi et al. U.S. Publication 2019/0046314 A1. Regarding Claim 3, Pelled et al. does not expressly disclose wherein each fiber of the plurality of fibers has a first extending direction and a plurality of undulations. Levi et al. teaches an implantable prosthetic valve 200 as seen in Figures 9 and 20 in the same field of endeavor comprising an annular frame 202 and a leaflet structure 14 positioned within the frame 202 (as seen in Figures 1-3 and paragraphs [0021-0022] and [0089]); an inner skirt 211 positioned along the inner surface of the frame 202 (paragraph [0090]); at least one outer skirt 212 positioned around the outer surface of the frame 202 (paragraph [0090]); wherein at least a portion of one of the leaflet structure, the inner skirt, or the at least one outer skirt comprises a material comprising a plurality of fibers (as seen in Figures 9-12B and 20), wherein at least one fiber of the plurality of fibers comprises electrospun silk (paragraph [0081]), wherein each fiber of the plurality of fibers has a first extending direction and a plurality of undulations (as seen in Figure 11, paragraphs [0090-0092]), for the purpose of having a skirt that is configured to promote sealing by obstructing blood flow past the skirt and increasing the dwell time of blood in the vicinity of the filaments (paragraph [0090]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include a plurality of fibers that has a first extending direction and a plurality of undulations as taught by Levi et al. for the purpose of having a skirt that is configured to promote sealing by obstructing blood flow past the skirt and increasing the dwell time of blood in the vicinity of the filaments. Claim(s) 21 and 29-30 is/are rejected under 35 U.S.C. 103 as being unpatentable over Levi et al. U.S. Publication 2019/0046314 A1 in view of Chadha et al. U.S. Publication 2017/0172736 A1. Regarding Claim 21, Pelled et al. discloses an implantable prosthetic valve comprising: an annular frame 310 having an inner surface and an outer surface (Figure 23-24), wherein the frame has an inflow end and an outflow end, and a central longitudinal axis extending from the inflow end to the outflow end; a leaflet structure 14 positioned within the frame (as seen in Figures 1-3 and paragraphs [0021-0022]); an inner skirt 302 positioned along the inner surface of the frame 12; at least one outer skirt 306 positioned around the outer surface of the frame 12; wherein at least a portion of one of the leaflet structure, the inner skirt, or the at least one outer skirt comprises a material comprising a plurality of fibers (paragraph [0065], [0069]) and wherein the implantable prosthetic valve is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration (abstract and paragraphs [0023], [0029] and [0057]). However, in the embodiment used in the rejection above, Figures 21-24 does not expressly disclose wherein at least one fiber of the plurality of fibers comprises electrospun silk. However, in an alternative embodiment, Figures 18-19f, Pelled et al. teaches a sealing member 16 formed from also laminated/encapsulated between one or more layers or filaments of ePTFE and fabric (paragraphs [0035-0036]), wherein the laminate sealing member is formed from a plurality of polymer fibers that is formed using an electrospining process ([0041], [0047] and [0069]) for the purpose of encapsulating the frame with the polymer sealing material using an electrical charge to drawn very fine fibers from a liquid to encapsulating the fibers to the frame (paragraph [0047]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include at least one fiber formed from electrospining as taught in Figures 18-20 for the purpose of encapsulating the frame with the polymer sealing material using an electrical charge to drawn very fine fibers from a liquid to encapsulating the fibers to the frame. However, Pelled et al. does not expressly disclose wherein the plurality of fibers have an average diameter from about 3 nm to 15,000 nm. Chadha et al. teaches an implantable heart valve (paragraph [0002], [0004]) in the same field of endeavor comprising a fabric forming an inner and outer fabric skirt, the fabric formed from a plurality of fibers formed from natural fibers such as silk (paragraph [0040]) and having an average diameter of about 10 microns to about 70 microns (paragraphs [0014], [0046]) for the purpose of altering the thickness of the fabric based on the size of the diameter (paragraph [0045]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include a plurality of fibers having an average diameter of at least 10 microns as taught by Chadha et al. for the purpose of altering the thickness of the fabric based on the size of the diameter. Regarding Claim 29, in the embodiment used in the rejection above, Figures 21-24 does not expressly disclose wherein at least a portion of the plurality of fibers has a random orientation or a predetermined aligned orientation. However, in an alternative embodiment, Figures 18-19f, Pelled et al. teaches a sealing skirt 16 in the same field of endeavor laminated/encapsulated between one or more layers or filaments of ePTFE and fabric (paragraphs [0035-0036]), wherein the laminate sealing member is formed from a plurality of polymer fibers that is formed using an electrospining process ([0041], [0047] and [0069]) and having a highly crystalline structure as well as having orientation relative to the axis of expansion to provide dimensional stability to the tubular material (paragraph [0049]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Figures 21-24 to further include a plurality of fibers that has a high crystalline structure and have orientation relative to the axis of expansion as taught in Figures 18-20 for the purpose of providing dimensional stability to the tubular structure. Regarding Claim 30, Pelled et al. discloses the first material, second material to be formed of PTFE, wherein the limitation “wherein the first material and/or the second material, and/or the third material exhibit tensile strength from greater than 0 MPa to about 20 MPa, and/or elongation at break from greater than 0% to about 600%, and/or a water contact angle from about 0° to about 180°” are material properties of said material. The prior art discloses the same material (ePTFE or PTFE) for the first and or second material, therefore, the disclosed polymeric material is fully capable of having the claimed material property of tensile strength and elongation and water contact angle. Claim(s) 22-27 is/are rejected under 35 U.S.C. 103 as being unpatentable over Levi et al. U.S. Publication 2019/0046314 A1 in view of Chadha et al. U.S. Publication 2017/0172736 A1 and further in view of Kaplan et al. U.S. Publication 2013/0172999 A1. Regarding Claim 22, Pelled et al. does not expressly disclose at least a portion of the first, second or third material exhibits porosity having an average pore size about 100 nm to about 100 micrometers. Kaplan et al. teaches an implant formed from a first layer 104, second layer 104, wherein the first and second layers are formed from silk fibroin (paragraphs [0021], [0023], [0056-0057]) and having pores, wherein the pores 106 have a size of about 100 microns (paragraph [0057]) wherein the pore size alters the porosity and interconnection of the channels of the pores to lower or increase the porosity of the silk layer (paragraphs [0063-0064]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Pelled’s skirt having a plurality of layers to further include a plurality of pores having a pore size of about 100 microns as taught by Kaplan for the purpose of altering the porosity of the silk layer. Regarding Claim 23, the limitation “wherein the average fiber diameter and/or pore size is controlled by a concentration of an active material in an electrospining solution” is a product by process limitation. Even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by- process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process (see MPEP 2113). Regarding Claim 24, Pelled et al. discloses the skirt 300 comprises a natural material, silk (see paragraph [0069]). Pelled et al. further discloses the skirt comprises a plurality of layers, wherein each of the plurality of layers is disposed on each other (paragraph [0071]). Regarding Claim 25, 26, Pelled et al. does not expressly disclose wherein the average fiber diameter or pore size is varied along the first material and or the second material. Kaplan et al. teaches an implant formed from a first layer 104, second layer 104, wherein the first and second layers are formed from silk fibroin (paragraphs [0021], [0023], [0056-0057]) and having pores, wherein the pores 106 are varied in each of the layers (paragraph [0073], [0106], [0115-0118]) to form distinct sub layer with distinct pore size distribution (paragraph [0119]) wherein the pore size alters the porosity and interconnection of the channels of the pores to lower or increase the porosity of the silk layer (paragraphs [0063-0064]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify Pelled’s skirt having a plurality of layers to further include a plurality of pores having varying pore sizes in each layer as taught by Kaplan for the purpose of altering the porosity of the silk layer. Regarding Claim 27, Pelled et al. discloses sealing member 300 having an inner skirt 302 and outer skirt 306 can be laminated with or encapsulated between one or more films of ePTFE (paragraph [0071]). However, in the embodiment used in the rejection above, Figures 21-24 does not expressly disclose wherein the plurality of fibers further comprises thermooplastic polyurethane (TPU), polyurethane (PU); implantable elastane polymer, or polyethylene, polypropylene, polymethylmethacrylate (PMMA), polystyrene (PS), polytetrafluoroethylene (PTFE), polyamide, polyethylene terephthalate (PET), polyethersulfone, poly-lactic-co-glycolic acid (PLGA). In an alternative embodiment as seen in Figures 18-19f, Pelled et al. teaches wherein the skirt comprises a plurality of fibers comprises PTFE fibers (see paragraph [0038] and [0041]) for the purpose of encapsulating portion of the frame with a plurality of layers that strengthen the sealing member 16 and resist tearing and prevent paravalvular leakage (paragraph [0039]). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the skirt of Pelled to further include a plurality of fibers formed from PTFE as taught in Figures 18-20 for the purpose of encapsulating portion of the frame with a plurality of layers of PTFE that strengthen the sealing member and resist tearing and prevent paravalvular leakage. Regarding Claim 28, Pelled et al. discloses the skirt 300 comprises a natural material, silk (see paragraph [0069]). Pelled et al. further discloses the skirt comprises a plurality of layers, wherein each of the plurality of layers is disposed on each other and formed of ePTFE (paragraph [0071]), therefore there is another layer without silk. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEEMA MATHEW whose telephone number is (571) 270-1452. The examiner can normally be reached on Monday-Friday 9 am – 5 pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, SPE, Melanie Tyson at (571) 272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEEMA MATHEW/ Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Oct 27, 2022
Application Filed
Aug 24, 2023
Response after Non-Final Action
Mar 06, 2025
Response after Non-Final Action
Aug 09, 2025
Non-Final Rejection — §103
Oct 30, 2025
Response Filed
Feb 21, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594161
SYSTEMS AND METHODS FOR PREDICTABLE COMMISSURAL ALIGNMENT OF A REPLACEMENT HEART VALVE
2y 5m to grant Granted Apr 07, 2026
Patent 12575929
INTEGRATED VALVE ASSEMBLY AND METHOD OF DELIVERING AND DEPLOYING AN INTEGRATED VALVE ASSEMBLY
2y 5m to grant Granted Mar 17, 2026
Patent 12564491
MULTI-LAYER COVERING FOR A PROSTHETIC HEART VALVE
2y 5m to grant Granted Mar 03, 2026
Patent 12551207
HEART VALVE PROSTHESIS AND METHOD
2y 5m to grant Granted Feb 17, 2026
Patent 12539422
Heart help device, system and method
2y 5m to grant Granted Feb 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
71%
Grant Probability
98%
With Interview (+26.5%)
3y 4m
Median Time to Grant
Moderate
PTA Risk
Based on 689 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month